Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HBAN
HBAN logo

HBAN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Huntington Bancshares Inc (HBAN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
15.370
1 Day change
2.30%
52 Week Range
19.450
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Huntington Bancshares Inc (HBAN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock is trading at a relatively low price and analysts maintain a generally positive outlook, the lack of immediate positive catalysts, insider selling, and mixed financial performance suggest holding off for now. The investor's impatience and unwillingness to wait for optimal entry points further support a hold recommendation.

Technical Analysis

The stock is showing bearish moving averages (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. MACD is positive but expanding only slightly, suggesting limited momentum. RSI is neutral at 44.791, and the stock is trading near its pivot level of 15.313, showing no strong directional bias.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
5

Positive Catalysts

  • Analysts maintain a generally positive outlook with multiple Buy and Overweight ratings. Recent price targets range from $19 to $23, indicating potential upside. The company's proven track record in acquisitions and integration is a long-term strength.

Neutral/Negative Catalysts

  • Insider selling has increased significantly (162.22% over the last month), which could indicate a lack of confidence from management. The company's Q4 financials showed a decline in net income (-4.42%) and EPS (-11.76%) YoY, which may weigh on investor sentiment. No recent news or event-driven catalysts to drive immediate upside.

Financial Performance

In Q4 2025, revenue increased by 11.26% YoY to $2.174 billion, showing growth in top-line performance. However, net income dropped by 4.42% YoY to $476 million, and EPS fell by 11.76% YoY to $0.30, reflecting challenges in profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain a generally positive outlook with multiple Buy and Overweight ratings. Recent price targets have been adjusted slightly downward due to macro risks but still indicate potential upside, with targets ranging from $19 to $23. Analysts highlight the company's strong management team and potential for synergies from recent acquisitions.

Wall Street analysts forecast HBAN stock price to rise
15 Analyst Rating
Wall Street analysts forecast HBAN stock price to rise
12 Buy
2 Hold
1 Sell
Moderate Buy
Current: 15.020
sliders
Low
16
Averages
20.23
High
23
Current: 15.020
sliders
Low
16
Averages
20.23
High
23
Morgan Stanley
analyst
Overweight
downgrade
$23 -> $21
AI Analysis
2026-03-31
New
Reason
Morgan Stanley
analyst
Price Target
$23 -> $21
AI Analysis
2026-03-31
New
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Huntington Bancshares to $21 from $23 and keeps an Overweight rating on the shares. The median bank stock in the firm's coverage is down by 5% over the past 30 days amid concerns about the potential impact of the ongoing Middle East conflict on economic growth and inflation, as well as market concerns on private credit headlines, notes the analyst, who is reducing price targets across the group by 9% on average as the firm applies lower target valuation multiples to reflect higher risk in the environment.
DA Davidson
Peter Winter
Buy
downgrade
$21 -> $20
2026-03-16
Reason
DA Davidson
Peter Winter
Price Target
$21 -> $20
2026-03-16
downgrade
Buy
Reason
DA Davidson analyst Peter Winter lowered the firm's price target on Huntington Bancshares to $20 from $21 and keeps a Buy rating on the shares. The stock has underperformed year-to-date given some execution risk of integrating two acquisitions, but this is a management team with a proven track record on bank integrations, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HBAN
Unlock Now

People Also Watch